A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control

eLife

Volumn 2013, Issue 2, 2013, Pages

  Bartha, István ^a,b,c,d   Carlson, Jonathan M ^e   Brumme, Chanson J ^f   McLaren, Paul J ^a,b,d   Brumme, Zabrina L ^f,g   John, Mina ^h   Haas, David W ⁱ   Martinez Picado, Javier ^j,k   Dalmau, Judith ^j   López Galíndez, Cecilio ^l   Casado, Concepción ^l   Rauch, Andri ^m   Günthard, Huldrych F ⁿ   Bernasconi, Enos ^o   Vernazza, Pietro ^p   Klimkait, Thomas ^q   Yerly, Sabine ^r   O'Brien, Stephen J ^s   Listgarten, Jennifer ^e   Pfeifer, Nico ^e,w   Lippert, Christoph ^e   Fusi, Nicolo ^e   Kutalik, Zoltán ^d,t   Allen, Todd M ^u   Müller, Viktor ^c   Richard Harrigan, P ^f,v   Heckerman, David ^e   Telenti, Amalio ^b   Fellay, Jacques ^a,b,d   more..

^a EPFL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^e MICROSOFT RESEARCH   (United States)

^f BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^g SIMON FRASER UNIVERSITY   (Canada)

^h MURDOCH UNIVERSITY   (Australia)

ⁱ VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^j UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^k INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^l INSTITUTO DE SALUD CARLOS III   (Spain)

^m UNIVERSITY OF BERN   (Switzerland)

ⁿ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^o REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^p CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^q UNIVERSITY OF BASEL   (Switzerland)

^r GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^s ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^t UNIVERSITY OF LAUSANNE   (Switzerland)

^u MASSACHUSETTS GENERAL HOSPITAL   (United States)

^v UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^w MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; HLA ANTIGEN CLASS 1; HOST FACTOR;

ARTICLE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; OUTCOME ASSESSMENT; PRINCIPAL COMPONENT ANALYSIS; SEQUENCE DATABASE; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; ALLELE; GENETICS; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; VIROLOGY; VIRUS GENOME;

ALLELES; GENOME, HUMAN; GENOME, VIRAL; GENOME-WIDE ASSOCIATION STUDY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; VIRAL LOAD;

EID: 84887377784     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.01123     Document Type: Article

References (42)

1. Alizon S, von Wyl V, Stadler T, Kouyos RD, Yerly S, Hirschel B, Böni J, et al. 2010. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLOS Pathogens 6:e1001123. doi: 10.1371/journal.ppat.1001123.
2. Almeida CA, Bronke C, Roberts SG, McKinnon E, Keane NM, Chopra A, Kadie C, et al. 2011. Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes. J Immunol 187:2502-13. doi: 10.4049/jimmunol.1100691.
3. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, Oniangue-Ndza C, et al. 2011. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476:96-100. doi: 10.1038/nature10237.
4. Bhattacharya T, Daniels M, Heckerman D, Foley B, Frahm N, Kadie C, Carlson J, et al. 2007. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 315:1583-6. doi: 10.1126/science.1131528.
5. Borghans JA, Mølgaard A, de Boer RJ, Keşmir C. 2007. HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 P24. PLOS ONE 2:e920. doi: 10.1371/journal.pone.0000920.
6. Brennan CA, Ibarrondo FJ, Sugar CA, Hausner MA, Shih R, Ng HL, Detels R, et al. 2012. Early HLA-B*57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progression. J Virol 86:10505-16. doi: 10.1128/JVI.00102-12.
7. Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M, Carlson J, Kadie C, et al. 2007. Evidence of differential HLA class i-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLOS Pathogens 3:e94. doi: 10.1371/journal.ppat.0030094.
8. Carlson JM, Brumme CJ, Martin E, Listgarten J, Brockman MA, Le AQ, Chui CK, et al. 2012. Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. J Virol 86:13202-16. doi: 10.1128/JVI.01998-12.
9. Carlson JM, Brumme ZL, Rousseau CM, Brumme CJ, Matthews P, Kadie C, Mullins JI, et al. 2008. Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag. Edited by Rob J De Boer. PLOS Comput Biol 4:23. doi: 10.1371/journal.pcbi.1000225.
10. Carlson JM, Listgarten J, Pfeifer N, Tan V, Kadie C, Walker BD, Ndung'u T, et al. 2012. Widespread impact of HLA restriction on immune control and escape pathways of HIV-1. J Virol 86:5230-43. doi: 10.1128/JVI.06728-11.
11. De Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, Seebregts C, Snoeck J, et al. 2005. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 21:3797-800. doi: 10.1093/bioinformatics/bti607.
12. Dyer WB, Zaunders JJ, Yuan FF, Wang B, Learmont JC, Geczy AF, Saksena NK, McPhee DA, Gorry PR, Sullivan JS. 2008. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to P24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection. Retrovirology 5:112. doi: 10.1186/1742-4690-5-112.
13. Evangelou E, Fellay J, Colombo S, Martinez-Picado J, Obel N, Goldstein DB, Telenti A, Ioannidis JPA. 2011. Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection. Am J Epidemiol 173:1336-42. doi: 10.1093/aje/kwr024.
14. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, et al. 2009. Common genetic variation and the control of HIV-1 in humans. PLOS Genet 5:e1000791. doi: 10.1371/journal.pgen.1000791.
15. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, et al. 2007. A Whole-genome association study of major determinants for host control of HIV-1. Science 317:944-7. doi: 10.1126/science.1143767.
16. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, Rosenberg ES, et al. 2001. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412:334-8. doi: 10.1038/35085576.
17. Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, et al. 2008. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an international AIDS Society-USA panel. Clin Infect Dis 47:266-85. doi: 10.1086/589297.
18. Iversen AKN, Stewart-Jones G, Learn GH, Christie N, Sylvester-Hviid C, Armitage AE, Kaul R, et al. 2006. Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat Immunol 7:179-89. doi: 10.1038/ni1298.
19. Jia X, Han B, Onengut-Gumuscu S, Chen WM, Concannon PJ, Rich SS, Raychaudhuri S, de Bakker PIW. 2013. Imputing amino acid polymorphisms in human leukocyte antigens. PLOS ONE 8:e64683. doi: 10.1371/journal.pone.0064683.
20. John M, Heckerman D, James I, Park LP, Carlson JM, Chopra A, Gaudieri S, et al. 2010. Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs. J Immunol 184:4368-77. doi: 10.4049/jimmunol.0903745.
21. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M, Gatanaga H, et al. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458:641-5. doi: 10.1038/nature07746.
22. Kirmaier A, Wu F, Newman RM, Hall LR, Morgan JS, O'Connor S, Marx PA, et al. 2010. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLOS Biol 8:e1000462. doi: 10.1371/journal.pbio.1000462.
23. Kouyos RD, von Wyl V, Yerly S, Böni J, Taffé P, Shah C, Bürgisser P, et al. 2010. Molecular epidemiology reveals long-term changes in hiv type 1 subtype B transmission in Switzerland. J Infect Dis 201:1488-97. doi: 10.1086/651951.
24. Medzhitov R, Schneider DS, Soares MP. 2012. Disease tolerance as a defense strategy. Science 335:936-41. doi: 10.1126/science.1214935.
25. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, von Mutius E, Farrall M, Lathrop M, Cookson WOCM. 2010. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363:1211-21. doi: 10.1056/NEJMoa0906312.
26. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-43. doi: 10.1126/science.1069660.
27. Ortiz M, Guex N, Patin E, Martin O, Xenarios I, Ciuffi A, Quintana-Murci L, Telenti A. 2009. Evolutionary trajectories of primate genes involved in HIV pathogenesis. Mol Biol Evol 26:2865-75. doi: 10.1093/molbev/msp197.
28. Pereyra F, Jia X, McLaren PJ. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330:1551-7. doi: 10.1126/science.1195271.
29. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904-9. doi: 10.1038/ng1847.
30. Purcell S, Cherny SS, Sham PC. 2003. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-50. doi: 10.1093/bioinformatics/19.1.149.
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, et al. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Human Genet 81:559-75. doi: 10.1086/519795.
32. Rahm N, Gfeller D, Snoeck J, Martinez R, McLaren PJ, Ortiz M, Ciuffi A, Telenti A. 2013. Susceptibility and adaptation to human TRIM5α alleles at positive selected sites in HIV-1 capsid. Virology:1-9. doi: 10.1016/j.virol.2013.03.021.
33. Rasetti R, Weinberger DR. 2011. Intermediate phenotypes in psychiatric disorders. Curr Opin Genet Dev 21:340-8. doi: 10.1016/j.gde.2011.02.003.
34. Sandonís V, Casado C, Alvaro T, Pernas M, Olivares I, García S, Rodríguez C, del Romero J, López-Galíndez C. 2009. A combination of defective DNA and protective host factors are found in a set of HIV-1 ancestral LTNPs. Virology 391:73-82. doi: 10.1016/j.virol.2009.05.022.
35. Schoeni-Affolter F, Ledergerber B, Rickenbach M, Rudin C, Günthard HF, Telenti A, Furrer H, Yerly S, Francioli P. 2010. Cohort profile: the Swiss HIV cohort study. Int J Epidemiol 39:1179-89. doi: 10.1093/ije/dyp321.
36. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wägele B, Altmaier E, et al. 2011. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477:54-60. doi: 10.1038/nature10354.
37. Telenti A, Johnson WE. 2012. Host genes important to HIV replication and evolution. Cold Spring Harbor Perspectives in Medicine 2:a007203. doi: 10.1101/cshperspect.a007203.
38. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, et al. 2012. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. J Am Med Assoc 308:387-402. doi: 10.1001/jama.2012.7961.
39. Von Wyl V, Kouyos RD, Yerly S, Böni J, Shah C, Bürgisser P, Klimkait T, et al. 2011. The Role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. J Infect Dis 204:1095-103. doi: 10.1093/infdis/jir491.
40. Von Wyl V, Yerly S, Bürgisser P, Klimkait T, Battegay M, Bernasconi E, Cavassini M, et al. 2009. Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clin Infect Dis 48:979-87. doi: 10.1086/597352.
41. Wain LV, Bailes E, Bibollet-Ruche F, Decker JM, Keele BF, Van Heuverswyn F, Li Y, et al. 2007. Adaptation of HIV-1 to its human host. Mol Biol Evol 24:1853-60. doi: 10.1093/molbev/msm110.
42. Wright JK, Brumme ZL, Julg B, van der Stok M, Mncube Z, Gao X, Carlson JM, et al. 2012. Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individuals. J Virol 86:1273-6. doi: 10.1128/JVI.06533-11.